Privia Health Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Privia Health Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	786	817	966	1,357	1,658	1,736	2,123
Selling and marketing	9.16	11.3	22.8	19.7	24.7	26.4	27.1
General and administrative	41.8	44	256	130	110	126	138
Operating expenses	770	792	1,184	1,376	1,637	1,719	2,089
Operating income	16.1	25.4	-217	-19.1	20.6	17	34.2
Interest expense	4	1.9	1.1	0.5
Other non-operating income				0.54	8.37	10.9	9.7
Pre-tax income	9.15	23.5	-219	-18.6	29	27.9	43.9
Income tax	1.21	-7.44	-27.9	-6.52	7.99	10.8	14.2
Net income to minority interests	-0.3	-0.34	-2.42	-3.48	-2.05	2.66	6.81
Net income	8.24	31.2	-188	-8.59	23.1	14.4	22.9
EBITDA	17.5	27.2	-215	-14.6	27.2	24.3	44.1
EPS, basic	0.09	0.33	-1.83	-0.08	0.20	0.12	0.19
EPS, diluted	0.09	0.33	-1.83	-0.08	0.19	0.11	0.18
Shares, basic (weighted)	95.9	96	103	111	117	119	122
Shares, diluted (weighted)	95.9	96	103	111	125	126	129

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	46.9	84.6	321	348	390	491	480
Receivables		99.1	117	190	291	316	401
Other current assets		6.33	8.7	14.4	20.5	27.5	30.4
Total current assets		190	447	552	701	835	911
Property, plant and equipment		4.81	4.5	3.39	2.33	1.24	0.5
Lease right-of-use assets		0	9.63	8.09	6.61	4.83	8.79
Goodwill		119	128	127	139	142	210
Intangible assets		5.98	59.7	57.4	108	110	216
Other non-current assets		4.48	4.52	4.68	8.58	17.1	21
Total assets		329	686	793	1,000	1,136	1,369
Accounts payable		5.24	2.97	6.73	7.88	9.76	7.97
Accrued liabilities		31.2
Total current liabilities		147	190	264	387	449	569
Long-term debt		32.8	31.7	0
Lease liabilities		0	11	8.49	5.25	3.04	7.33
Other non-current liabilities		5.6	3	1	0.31	0.15	2.58
Total liabilities		185	236	274	393	452	578
Paid-in capital		166	634	715	754	813	892
Retained earnings		-19.9	-208	-217	-194	-179	-156
Shareholders' equity		147	427	499	561	635	737
Minority interests		-3.1	23.3	20	46	48.3	53.7
Total equity	107	144	450	519	607	683	791
Total liabilities and equity		329	686	793	1,000	1,136	1,369
Shares outstanding		96	108	115	118	120	124

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	7.95	30.9	-191	-12.1	21	17	29.7
Depreciation and amortization	1.43	1.84	2.46	4.57	6.53	7.27	9.91
Stock-based compensation	0.21	0.48	254	67.4	37.1	56.7	71.1
Deferred income tax	0.72	-7.83	-28.4	-7	7.47	8.82	10.9
Change in receivables	-6.18	-21.8	-14.6	-72.2	-96.9	-19.8	-36.7
Change in payables	2.08	9.71	1.26	6.85	4.99	19.9	14.8
Cash from operations	24.4	38.9	55.1	47.2	80.8	109	163
Capital expenditures	-5.71	-0.38	-0.55	-0.1	-0.11
Acquisitions	0	0	-32.2	0	-42.9	-6.96	-180
Cash from investing	-5.71	-0.38	-32.8	-0.1	-43	-12	-182
Stock issued	0	0.11	3.83	13.4	8.74	2.68	8.05
Cash from financing	-10.9	-0.77	214	-19.7	3.71	4.33	6.7
Net change in cash	7.78	37.7	236	27.4	41.5	102	-11.5
Free cash flow	18.6	38.5	54.5	47.1	80.7
Interest paid	9.2	1.93	0.89	0.71	0.04	0.29	0.25
Income taxes paid	0.32	0.38	0.5	0.31	1.04	3.76	6.64

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $19.71 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	1.9%	Operating income / revenue.
EBITDA margin	2.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.4%	Pre-tax income / revenue.
Net margin	1.2%	Net income / revenue.
Operating cash flow margin	5.6%	Cash from operations / revenue.
Effective tax rate	39.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.9%	Net income / average total assets.
Return on invested capital (ROIC)	7.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	3.2%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	22.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	16.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	21.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	101.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	6.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	82.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	10.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	59.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-6.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	63.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-11.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	49.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	51.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	33.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	16.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	38.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	20.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	20.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	33.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	6.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.62x	Current assets / current liabilities.
Quick ratio	1.55x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.65x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	43.7%	Total liabilities / total assets.
Working capital	$390.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	29.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$347.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.58x	Revenue / average total assets.
Fixed asset turnover	8,669x	Revenue / average property, plant and equipment.
Receivables turnover	4.11x	Revenue / average receivables.
Days sales outstanding	89 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$17.89	Revenue / diluted weighted shares.
Operating cash flow per share	$0.99	Cash from operations / diluted weighted shares.
Book value per share	$6.19	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.75	Tangible book value / shares outstanding.
Cash per share	$3.26	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.52B	Share price x shares outstanding.
Enterprise value	$2.11B	Market cap + total debt - cash - short-term investments.
P/E	89.5x	Market cap / net income. Only when net income is positive.
P/S	1.07x	Market cap / revenue.
P/B	3.22x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	7.24x	Market cap / tangible book value, when positive.
P/OCF	19.2x	Market cap / cash from operations, when positive.
EV/Sales	0.89x	Enterprise value / revenue.
EV/EBIT	46.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	37.0x	Enterprise value / EBITDA, when both are positive.
Earnings yield	1.1%	Net income / market cap (the inverse of P/E).

What was Privia Health Group, Inc.'s revenue in fiscal 2025?

Privia Health Group, Inc. reported revenue of $2.12B for fiscal 2025, 22.3% higher than the year before.

Was Privia Health Group, Inc. profitable in fiscal 2025?

Yes. Net income was $22.9M, a net margin of 1.1%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Privia Health Group, Inc.